Document ID: chunk:federal_register_of_legislation:F2022L01113:reg:9:p2
Version: federal_register_of_legislation:F2022L01113
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6716–8651

ethylene oxide vapour can occur during the sterilisation of surgical instruments or protective clothing in hospitals.
Note 2: ppm-years is defined in the Schedule 1 - Dictionary.

(6)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the bone marrow at least 5 years before the clinical onset of mature B-cell lymphoid leukaemia or small lymphocytic lymphoma;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(7)          inhaling 1,3-butadiene gas as specified:
(a)          for a cumulative total of at least 2,500 hours within a continuous period of 10 years before the clinical onset of mature B-cell lymphoid leukaemia or small lymphocytic lymphoma; and
(b)          where the first exposure in that period occurred at least 5 years before the clinical onset of mature B-cell lymphoid leukaemia or small lymphocytic lymphoma;
                Note 1: Inhalation of 1,3-butadiene gas can occur during the distribution of petrol, manufacture of rubber and plastic products, and from breathing smoke from fires.
                Note 2: Inhaling 1,3-butadiene gas as specified is defined in the Schedule 1 - Dictionary.
(8)          being exposed to 1,3-butadiene:
(a)          in an amount greater than 100 ppm-years of cumulative exposure before the clinical onset of mature B-cell lymphoid leukaemia or small lymphocytic lymphoma; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of mature B-cell lymphoid leukaemia or small lymphocytic lymphoma;
Note 1: Inhalation of 1,3-butadiene gas can occur during the distribution of petrol, manufacture of rubber and plastic products, and from breathing smoke from fires.
Note 2: ppm-years is defined in the Schedule 1 - Dictionary.
(9)          inability to obtain appropriate clinical management for mature B-cell lymphoid leukaemia and small lymphocytic lymphoma.